Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Osteoporos Int. 2020 Sep 15;32(3):515–527. doi: 10.1007/s00198-020-05619-2

Table 4: Association between actigraphy-determined continuous nocturnal sleep duration and BMD by 25OHD level in fully adjusted model.

Data presented as the difference in BMD (g/cm2) per additional hour of sleep (β) ± SEE (p-value). Adjusted for age, race, clinical site, BMI, alcohol, season of 25-hydroxyvitamin D blood draw, eGFR, daily naps, hours of sleep needed to feel rested, melatonin level, calcium use, androgen use, anti-androgen use, PASE Score, self-reported health status

25OHD <20 ng/mL 25OHD 20-29 ng/mL 25OHD ≥30 ng/mL
N (%) 228 744 792
L-spine 0.023 ± 0.015 (p = 0.12) 0.011 ± 0.009 (p = 0.25) −0.003 ± 0.008 (p = 0.67)
Total Hip 0.016 ± 0.008 (p = 0.04) 0.003 ± 0.004 (p = 0.43) 0.003 ±0.004 (p = 0.44)
Femoral Neck 0.011 ± 0.007 (p = 0.12) 0.0002 ± 0.004 (p = 0.97) 0.004 ± 0.004 (p = 0.31)